Liver Cancer and Smoking

Reviewed by:
Jessica Loong MSci Pharmacology (2026)
Richa Lal MBBS, PG Anaesthesia (University of Mumbai)

Introduction 

Liver cancer is one of the most serious and life-threatening malignancies worldwide, with high mortality rates and limited treatment options. The disease primarily develops due to chronic liver damage, cirrhosis, and exposure to carcinogens, among other factors. One of the lesser-known but significant risk factors for liver cancer is smoking. 

Studies have shown that smoking increases the likelihood of liver cancer by promoting liver damage, inflammation, and genetic mutations in liver cells.1 Despite growing awareness of the dangers of smoking, many individuals remain unaware of its direct impact on liver health. This article explores the relationship between smoking and liver cancer, highlighting the mechanisms by which tobacco use contributes to the disease.2

Understanding liver cancer

Liver cancer develops when liver cells grow uncontrollably, forming tumours. The most common type of liver cancer is hepatocellular carcinoma (HCC), which arises from hepatocytes, the main liver cells. Other types include cholangiocarcinoma (bile duct cancer) and angiosarcoma, a rare cancer affecting blood vessels in the liver.

Risk factors for liver cancer

Liver cancer is influenced by various factors, including:

  • Chronic hepatitis B and C infections: Viral infections cause liver inflammation, leading to fibrosis and cirrhosis, which increase cancer risk3
  • Alcohol consumption: Excessive alcohol intake leads to liver damage, fatty liver disease, and cirrhosis
  • Obesity and non-alcoholic fatty liver disease (NAFLD): Excess fat in the liver increases cancer risk
  • Aflatoxin exposure: This toxin, found in contaminated food, damages liver cells
  • Smoking: Tobacco contains carcinogens that can damage the liver's DNA, leading to cancer4

How smoking contributes to liver cancer

Smoking affects the liver in multiple ways, from direct exposure to carcinogens to indirect effects on liver function and metabolism.

Carcinogenic compounds in cigarettes

There are lots of carcinogens in cigarettes, and they have more than 7,000 chemicals. Some of these harmful compounds include benzene, arsenic, formaldehyde, and polycyclic aromatic hydrocarbons (PAHs), which can induce mutations in liver cells.5 These chemicals enter the bloodstream through the lungs and are metabolised by the liver, leading to toxic byproducts that cause liver cell damage.

Oxidative stress and inflammation

Smoking triggers oxidative stress, a condition where harmful free radicals accumulate and damage liver cells. This results in chronic inflammation, a key driver of liver fibrosis and cirrhosis. Over time, persistent inflammation increases the likelihood of cancerous transformations in liver cells.6,8

Impaired detoxification function of the liver

The liver is responsible for detoxifying harmful substances, including tobacco toxins. However, smoking overwhelms this detoxification system, leading to the accumulation of toxic metabolites. This weakens liver function and makes it more susceptible to diseases, including cancer.7

Synergistic effect with other liver cancer risk factors

Smoking does not act alone in increasing the risk of liver cancer. It exacerbates the effects of other risk factors such as hepatitis infections, alcohol consumption, and obesity.9 For example:

  • Hepatitis B and C patients who smoke have a higher risk of developing liver cancer than non-smokers with hepatitis
  • Smoking and alcohol consumption together accelerate liver cirrhosis, a major precursor to liver cancer

Scientific studies linking smoking and liver cancer

Several studies have confirmed the role of smoking in liver cancer development:1,3,9

  • A study published in the Journal of Hepatology found that smokers have a 50% higher risk of developing liver cancer compared to non-smokers
  • Research conducted by the World Health Organization (WHO) concluded that smoking contributes to one in five liver cancer cases globally
  • A meta-analysis published in Cancer Epidemiology demonstrated that the risk of liver cancer increases with the duration and intensity of smoking, meaning that heavy smokers are at the highest risk

Symptoms of liver cancer

Liver cancer often remains undetected in its early stages due to mild or nonspecific symptoms. As the disease starts growing, patients may experience:

  • Unexplained weight loss
  • Loss of appetite and nausea
  • Persistent fatigue and weakness
  • Abdominal pain and swelling
  • Jaundice (yellowing of the skin and eyes)
  • Dark urine and pale stools
  • Enlarged liver or spleen

Prevention and risk reduction strategies

Since smoking is a preventable risk factor for liver cancer, quitting can significantly reduce the risk. Here are effective strategies for prevention:

Smoking cessation

  • Nicotine replacement therapy (NRT): Helps manage withdrawal symptoms
  • Medications: Drugs like varenicline and bupropion aid in quitting
  • Counselling and support groups: Professional counselling and quit-smoking programs improve success rates
  • Lifestyle changes: Engaging in physical activities, maintaining a balanced diet, and reducing stress help curb smoking cravings

Vaccination

Since hepatitis infections increase liver cancer risk, vaccination against hepatitis B and proper treatment for hepatitis C are essential.

Reducing alcohol consumption

Limiting alcohol intake protects the liver from damage and lowers the risk.

Eating a healthy diet

A diet rich in fruits, vegetables, whole grains, and lean proteins supports liver function and detoxification.

Regular medical check-ups

Routine screenings, including liver function tests and imaging scans, can detect early signs of liver damage or cancer.

Summary

Liver cancer is a serious disease with a strong link to smoking. The carcinogens in tobacco products contribute to liver cell mutations, oxidative stress, and chronic inflammation, increasing the risk of liver cancer. Scientific evidence confirms that smoking, especially when combined with other risk factors like hepatitis and alcohol, significantly raises the likelihood of developing the disease. 

The good news is that quitting smoking, combined with healthy lifestyle choices, can dramatically reduce liver cancer risk. Public awareness campaigns and smoking cessation programs play a crucial role in lowering tobacco-related liver cancer cases. Hence, individuals can protect their liver health and improve their overall well-being by taking preventive measures and promoting healthier choices.

References

  1. Lee Y-CA, Cohet C, Yang Y-C, Stayner L, Hashibe M, Straif K. Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer. International Journal of Epidemiology [Internet]. 2009 [cited 2025 Apr 15]; 38(6):1497–511. Available from: https://academic.oup.com/ije/article-lookup/doi/10.1093/ije/dyp280.
  2. Zhang Y, Li Z-Y, Shen Q-M, Tuo J-Y, Tan J-Y, Tan Y-T, et al. A prospective cohort study of cigarette smoking, alcohol drinking and liver cancer incidence in Chinese men. J Dig Dis [Internet]. 2022 [cited 2025 Apr 15]; 23(8–9):527–34. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9722635/.
  3. Jain D, Chaudhary P, Varshney N, Bin Razzak KS, Verma D, Khan Zahra TR, et al. Tobacco Smoking and Liver Cancer Risk: Potential Avenues for Carcinogenesis. J Oncol [Internet]. 2021 [cited 2025 Apr 15]; 2021:5905357. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683172/.
  4. Tang M, Lee H-W, Weng M, Wang H-T, Hu Y, Chen L-C, et al. DNA Damage, DNA Repair and Carcinogenicity: Tobacco Smoke versus Electronic Cigarette Aerosol. Mutat Res Rev Mutat Res [Internet]. 2022 [cited 2025 Apr 15]; 789:108409. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208310/.
  5. Hassan M, Selimovic D, Ghozlan H, Abdel-kader O. Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways #. Hepatology [Internet]. 2009 [cited 2025 Apr 15]; 49(5):1469–82. Available from: https://journals.lww.com/01515467-200905000-00010.
  6. Chuang S-C, Lee Y-CA, Wu G-J, Straif K, Hashibe M. Alcohol consumption and liver cancer risk: a meta-analysis. Cancer Causes Control [Internet]. 2015 [cited 2025 Apr 15]; 26(9):1205–31. Available from: http://link.springer.com/10.1007/s10552-015-0615-3.
  7. Stickel F, Moreno C, Hampe J, Morgan MY. The genetics of alcohol dependence and alcohol-related liver disease. Journal of Hepatology [Internet]. 2017 [cited 2025 Apr 15]; 66(1):195–211. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0168827816304433.
  8. Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, et al. Oxidative Stress: Harms and Benefits for Human Health. Oxid Med Cell Longev [Internet]. 2017 [cited 2025 Apr 15]; 2017:8416763. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551541/.
  9. Marti-Aguado D, Clemente-Sanchez A, Bataller R. Cigarette smoking and liver diseases. Journal of Hepatology [Internet]. 2022 [cited 2025 Apr 15]; 77(1):191–205. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0168827822000290.

Syed Mohammed Reyan

Bachelor of Pharmacy - BPharm, Pharmaceutical Sciences, Dayananda Sagar University

Knowledge and skills about medical writing.

my.klarity.health presents all health information in line with our terms and conditions. It is essential to understand that the medical information available on our platform is not intended to substitute the relationship between a patient and their physician or doctor, as well as any medical guidance they offer. Always consult with a healthcare professional before making any decisions based on the information found on our website.
Klarity is a citizen-centric health data management platform that enables citizens to securely access, control and share their own health data. Klarity Health Library aims to provide clear and evidence-based health and wellness related informative articles. 
Email:
Klarity / Managed Self Ltd
Alum House
5 Alum Chine Road
Westbourne Bournemouth BH4 8DT
VAT Number: 362 5758 74
Company Number: 10696687

Phone Number:

 +44 20 3239 9818
arrow-right